Search Results
Search for other papers by Aran Son in
Google Scholar
PubMed
BK21 PLUS Project, Yonsei University College of Dentistry, Seoul, Korea
Search for other papers by Namju Kang in
Google Scholar
PubMed
Search for other papers by Sue Young Oh in
Google Scholar
PubMed
Search for other papers by Ki Woo Kim in
Google Scholar
PubMed
Search for other papers by Shmuel Muallem in
Google Scholar
PubMed
Search for other papers by Yu-Mi Yang in
Google Scholar
PubMed
BK21 PLUS Project, Yonsei University College of Dentistry, Seoul, Korea
Search for other papers by Dong Min Shin in
Google Scholar
PubMed
. One is receptor activator of nuclear factor-kappa B ligand (RANKL) secreted by osteoblasts. The other is macrophage-colony-stimulating factor (M-CSF) ( Takayanagi 2007 ). RANK receptor’s activation by RANKL leads to oscillations in intracellular Ca 2
Search for other papers by Soo Yeon Jang in
Google Scholar
PubMed
Search for other papers by Kyung Mook Choi in
Google Scholar
PubMed
synergistic effect between these two diseases remains controversial ( Scott et al. 2019 , Zanker & Duque 2020 ). The receptor activator of NFκB (RANK) ligand (RANKL) is a cytokine in the tumor necrosis factor (TNF) superfamily ( Ono et al. 2020 ). It is
Department of Cell Biology, Aging Science, and Pharmacology, Division of Oral Biological Sciences, Faculty of Dental Science, Kyushu University, Higashi-ku, Fukuoka, Japan
Section of Implant and Rehabilitative Dentistry, Division of Oral Rehabilitation, Kyushu University, Higashi-ku, Fukuoka, Japan
Search for other papers by Kayo Mori in
Google Scholar
PubMed
Search for other papers by Akiko Mizokami in
Google Scholar
PubMed
Search for other papers by Tomomi Sano in
Google Scholar
PubMed
Search for other papers by Satoru Mukai in
Google Scholar
PubMed
Search for other papers by Fumitaka Hiura in
Google Scholar
PubMed
Search for other papers by Yasunori Ayukawa in
Google Scholar
PubMed
Search for other papers by Kiyoshi Koyano in
Google Scholar
PubMed
Search for other papers by Takashi Kanematsu in
Google Scholar
PubMed
Oral Health/Brain Health/Total Health Research Center, Kyushu University, Higashi-ku, Fukuoka, Japan
Search for other papers by Eijiro Jimi in
Google Scholar
PubMed
supplementary signaling axis that cooperates with the canonical NF-κB pathway in regulating specific functions of the adaptive immune system ( Sun et al. 2017 ). Circulating levels of receptor activator of NF-κB ligand (RANKL) are elevated in animal models
Search for other papers by GP Thomas in
Google Scholar
PubMed
Search for other papers by SU Baker in
Google Scholar
PubMed
Search for other papers by JA Eisman in
Google Scholar
PubMed
Search for other papers by EM Gardiner in
Google Scholar
PubMed
Osteoblast-osteoclast coordination is critical in the maintenance of skeletal integrity. The modulation of osteoclastogenesis by immature cells of the osteoblastic lineage is mediated through receptor activator of NF kappa B (RANK), its ligand RANKL, and osteoprotegerin (OPG), a natural decoy receptor for RANKL. Here, the expression of OPG and RANKL in primary mouse osteoblastic cultures was investigated to determine whether the osteoclastogenic stimulus depended on the stage of osteoblastic differentiation and the presence of the calciotrophic hormone 1,25-dihydroxyvitamin D(3) (1,25-(OH)(2)D(3)). OPG mRNA expression was increased in osteoblastic cultures after the onset of mineralisation relative to less mature cultures, but did not alter in response to 1,25-(OH)(2)D(3) treatment. In contrast, basal RANK L mRNA expression did not change during differentiation but was significantly enhanced by 1,25-(OH)(2)D(3) treatment at all times. The stimulatory effects of 1,25-(OH)(2)D(3) on RANKL were lessened in more mature cultures, however. The RANKL/OPG ratio, an index of osteoclastogenic stimulus, was therefore increased by 1,25-(OH)(2)D(3) treatment at all stages of osteoblastic differentiation, but to a lesser degree in cultures after the onset of mineralisation. Thus the 1,25-(OH)(2)D(3)-driven increase in osteoclastogenic potential of immature osteoblasts appears to be mediated by increased RANKL mRNA expression, with mature osteoblasts having relatively decreased osteoclastogenic activity due to increased OPG mRNA expression. These findings suggest a possible mechanism for the recently proposed negative regulatory role of mature osteoblasts on osteoclastogenesis and indicate that the relative proportions of immature and mature osteoblasts in the local microenvironment may control the degree of resorption at each specific bone site.
Search for other papers by Dan Li in
Google Scholar
PubMed
Search for other papers by Yan Ji in
Google Scholar
PubMed
Search for other papers by Chunlan Zhao in
Google Scholar
PubMed
Search for other papers by Yapeng Yao in
Google Scholar
PubMed
Search for other papers by Anlan Yang in
Google Scholar
PubMed
Search for other papers by Honghong Jin in
Google Scholar
PubMed
Search for other papers by Yang Chen in
Google Scholar
PubMed
Search for other papers by Mingjun San in
Google Scholar
PubMed
Search for other papers by Jing Zhang in
Google Scholar
PubMed
Search for other papers by Mingjiao Zhang in
Google Scholar
PubMed
Key Laboratory of Molecular Epigenetics of Ministry of Education, Northeast Normal University, Changchun, Jilin, China
Search for other papers by Luqing Zhang in
Google Scholar
PubMed
Key Laboratory of Molecular Epigenetics of Ministry of Education, Northeast Normal University, Changchun, Jilin, China
Search for other papers by Xuechao Feng in
Google Scholar
PubMed
Key Laboratory of Molecular Epigenetics of Ministry of Education, Northeast Normal University, Changchun, Jilin, China
Search for other papers by Yaowu Zheng in
Google Scholar
PubMed
epithelium proliferation, ductal side-branching and alveolar morphogenesis during pregnancy ( Brisken et al. 1998 , Mulac-Jericevic et al. 2003 ). Receptor activator of NFKB1 ligand (RANKL) mediates mouse mammary epithelium proliferative response to P4
Search for other papers by M Takamoto in
Google Scholar
PubMed
Search for other papers by K Tsuji in
Google Scholar
PubMed
Search for other papers by T Yamashita in
Google Scholar
PubMed
Search for other papers by H Sasaki in
Google Scholar
PubMed
Search for other papers by T Yano in
Google Scholar
PubMed
Search for other papers by Y Taketani in
Google Scholar
PubMed
Search for other papers by T Komori in
Google Scholar
PubMed
Search for other papers by A Nifuji in
Google Scholar
PubMed
Search for other papers by M Noda in
Google Scholar
PubMed
Hedgehog signaling is considered to play a crucial role in chondrogenesis by regulation through a network of cytokine actions, which is not fully understood. We examined the effect of hedgehog signaling on the expression of core-binding factor a1 (Cbfa1), a critical transcription factor for the development of bone and cartilage. Primary chondrocytes prepared from the costal cartilage of newborn mice were treated with N-terminal fragment of recombinant murine sonic hedgehog (rmShh-N). Northern blot analysis indicated that Cbfa1 mRNA expression levels in the chondrocyte cultures were elevated by the treatment with rmShh-N. rmShh-N treatment enhanced 1.8 kb Cbfa1 promoter activity in chondrocytes, suggesting the presence of transcriptional control. As Cbfa1-binding site(s) have been located in the promoter of the receptor activator of nuclear factor-kappaB (RANK) ligand (RANKL) gene, we also examined RANKL expression. rmShh-N treatment upregulated RANKL and RANK mRNA expression levels in chondrocytes. Interestingly, RANKL suppressed the hedgehog enhancement of alkaline phosphatase activity in chondrocytes, suggesting the presence of a link between these signaling molecules. We conclude that hedgehog signaling activates Cbfa1 gene expression through its promoter in chondrocytes, and also activates and interacts with RANKL to maintain cartilage development.
Search for other papers by MK Lindberg in
Google Scholar
PubMed
Search for other papers by M Erlandsson in
Google Scholar
PubMed
Search for other papers by SL Alatalo in
Google Scholar
PubMed
Search for other papers by S Windahl in
Google Scholar
PubMed
Search for other papers by G Andersson in
Google Scholar
PubMed
Search for other papers by JM Halleen in
Google Scholar
PubMed
Search for other papers by H Carlsten in
Google Scholar
PubMed
Search for other papers by JA Gustafsson in
Google Scholar
PubMed
Search for other papers by C Ohlsson in
Google Scholar
PubMed
Estrogens are important for the male skeleton. Osteoprotegerin (OPG), receptor activator of NF-kappa B ligand (RANKL), interleukin-6 (IL-6), IL-1 and tumor necrosis factor alpha (TNFalpha) have been suggested to be involved in the skeletal effects of estrogen. We treated orchidectomized mice with estradiol for 2 weeks and observed a 143% increase in the trabecular bone mineral density of the distal metaphysis of femur that was associated with a decreased OPG/RANKL mRNA ratio in vertebral bone. A similar decreased OPG/RANKL ratio was also seen after estrogen treatment of ovariectomized female mice. The effect of estrogen receptor (ER) inactivation on the OPG/RANKL ratio was dissected by using intact male mice lacking ER alpha (ERKO), ER beta (BERKO) or both receptors (DERKO). The expression of OPG was increased in ERKO and DERKO but not in BERKO male mice, resulting in an increased OPG/RANKL ratio. Furthermore, serum levels of IL-6 and tartrate-resistant acid phosphatase 5b (TRAP 5b) were decreased in ERKO and DERKO, but not in BERKO male mice. These results demonstrate that ER alpha, but not ER beta, is involved in the regulation of the vertebral OPG/RANKL ratio, serum levels of IL-6 and TRAP 5b in male mice.
Search for other papers by T Watanabe in
Google Scholar
PubMed
Search for other papers by T Kukita in
Google Scholar
PubMed
Search for other papers by A Kukita in
Google Scholar
PubMed
Search for other papers by N Wada in
Google Scholar
PubMed
Search for other papers by K Toh in
Google Scholar
PubMed
Search for other papers by K Nagata in
Google Scholar
PubMed
Search for other papers by H Nomiyama in
Google Scholar
PubMed
Search for other papers by T Iijima in
Google Scholar
PubMed
Macrophage inflammatory protein-1alpha (MIP-1alpha) is a member of the CC chemokines. We have previously reported the use of a whole bone marrow culture system to show that MIP-1alpha stimulates the formation of osteoclast-like multinucleated cells. Here we use rat bone marrow cells deprived of stromal cells, and clones obtained from murine macrophage-like cell line RAW264 to show that MIP-1alpha acts directly on cells in osteoclast lineage. We obtained several types of RAW264 cell clones, one of these clones, designated as RAW264 cell D clone (D clone), showed an extremely high response to receptor activator of NFkappaB ligand (RANKL) and tumor necrosis factor-alpha (TNF-alpha), while the other clone, RAW264 cell N clone (N clone), demonstrated no response to RANKL or TNF-alpha. Although both clones expressed receptor activator NFkappaB (RANK) before being stimulated for differentiation, only the D clone expressed cathepsin K when cells were stimulated to differentiate to osteoclasts. MIP-1alpha stimulated the formation of mononuclear preosteoclast-like cells from rat bone marrow cells deprived of stromal cells. MIP-1alpha also stimulated formation of osteoclast-like multinucleated cells from the D clone, when these cells were stimulated with RANKL and TNF-alpha. These findings provide strong evidence to show that MIP-1alpha acts directly on cells in the osteoclast lineage to stimulate osteoclastogenesis. Furthermore, pretreatment of RAW264 cell D clone with MIP-1alpha significantly induced adhesion properties of these cells to primary osteoblasts, suggesting a crucial role for MIP-1alpha in the regulation of the interaction between osteoclast precursors and osteoblasts in osteoclastogenesis.
Search for other papers by J Cheung in
Google Scholar
PubMed
Search for other papers by YT Mak in
Google Scholar
PubMed
Search for other papers by S Papaioannou in
Google Scholar
PubMed
Search for other papers by BA Evans in
Google Scholar
PubMed
Search for other papers by I Fogelman in
Google Scholar
PubMed
Search for other papers by G Hampson in
Google Scholar
PubMed
Oestrogen inhibits bone resorption, at least in part, by regulating the production of several cytokines, including interleukin-6 (IL-6), IL-1, receptor activator of nuclear factor kappaB ligand (RANKL) and osteoprotegerin (OPG) by cells of the osteoblastic lineage. The selective oestrogen receptor modulator raloxifene (RAL) acts on bone in a similar manner to oestrogen, although the mechanisms of action of RAL on osteoblasts still remain unclear. We investigated and compared the effects of 17-beta oestradiol (E(2)) and RAL on the regulation of IL-6, IL-1, RANKL and OPG in vitro in primary human osteoblastic (HOB) cells and in an immortalised clonal human bone marrow stromal cell line (HCC1) with osteoblastic characteristics. We tested E(2) and RAL at concentrations ranging from 10(-12) to 10(-6) M. IL-6, IL-1alpha and IL-1beta, OPG and RANKL were measured by ELISA. RANKL and OPG mRNA steady state level was assessed by quantitative PCR analysis. Both E(2) and RAL led to a significant reduction in IL-6 production in the HOB cells, although the effect was more marked with E(2) (P<0.05). IL-1alpha and IL-1beta also decreased significantly following treatment with E(2) and RAL in the HCC1 cells (E(2) (10(-8), 10(-7) and 10(-6) M), % reduction (means+/-S.E.M.) compared with vehicle-treated cells - IL-1alpha: 84+/-7.4, 70.8+/-2.9*, 78.2+/-4.8*; IL-1beta: 79+/-10, 72.8+/-8.2*, 66.6+/-2.8*; RAL (10(-8), 10(-7) and 10(-6) M) - IL-1alpha: 72.4+/-5*, 79+/- 5.2*, 102+/-7.7; IL-1beta: 67.9+/-3.2*, 69+/-2.5*, 73.8+/- 6.2*; *P<0.05). OPG protein concentration decreased significantly in a dose-dependent manner following treatment with E(2) and RAL (% reduction E(2) (10(-8), 10(-7) and 10(-6) M) - HOB: 72.5+/-8.4*, 80+/-6.7*, 62.8+/-8.9*; HCC1: 109+/-4, 98.8+/-6, 54.5+/-3.4*; RAL (10(-8), 10(-7) and 10(-6) M) - HOB: 81.5+/-5.5*, 62.7+/-7.4*, 55.2+/-10.9*; HCC1: 92.7+/-7.4, 67+/-12.2*, 39+/-4.5*; *P<0.05). In the HCC1 cells, RANKL protein did not change significantly following E(2). In contrast, a significant reduction in RANKL was seen with RAL at 10(-7) and 10(-6) M (66+/-6.4% and 74+/-3% respectively). There was no change in OPG mRNA expression following E(2) or RAL in the HCC1 cells, although in the HOB cells we observed a significant reduction in OPG mRNA. RANKL mRNA decreased significantly in the HCC1 cells following RAL (10(-8), 10(-7)and 10(-6) M) treatment (% change from controls: 52+/-2*, 62+/-1*, 53+/-5.8*; *P<0.05). Similar results were seen in the HOB cells with RAL at 10(-6) M (RANKL mRNA: 72+/-5.5, P<0.05). In addition, there was a significant decrease in the RANKL/OPG ratio after RAL at 10(-6) M (HOB: 65.6+/-5*, HCC1: 56.9+/-20*; *P<0.05). RANKL/OPG ratio did not change significantly in the HCC1 cells following E(2). However, in contrast to RAL, we observed an increase in the RANKL/OPG ratio in the HOB cells following treatment with E(2). In conclusion, the study shows that RAL and E(2) have divergent cell-specific effects on the regulation of cytokines. The data also suggest that, in contrast to E(2), RAL may exert its anti-resorptive actions, at least in part, via the RANKL/OPG pathway. Further in vivo studies are required to confirm this.
Asan Institute for Life Sciences, Seoul, Republic of Korea
Department of Cell and Developmental Biology, Dental Research Institute, Seoul National University, Seoul, Republic of Korea
Department of Thoracic and Cardiovascular Surgery, University of Ulsan College of Medicine, Asan Medical Center, Seoul, Republic of Korea
Search for other papers by Jung-Min Koh in
Google Scholar
PubMed
Asan Institute for Life Sciences, Seoul, Republic of Korea
Department of Cell and Developmental Biology, Dental Research Institute, Seoul National University, Seoul, Republic of Korea
Department of Thoracic and Cardiovascular Surgery, University of Ulsan College of Medicine, Asan Medical Center, Seoul, Republic of Korea
Search for other papers by Young-Sun Lee in
Google Scholar
PubMed
Asan Institute for Life Sciences, Seoul, Republic of Korea
Department of Cell and Developmental Biology, Dental Research Institute, Seoul National University, Seoul, Republic of Korea
Department of Thoracic and Cardiovascular Surgery, University of Ulsan College of Medicine, Asan Medical Center, Seoul, Republic of Korea
Search for other papers by Chang-Hyun Byun in
Google Scholar
PubMed
Asan Institute for Life Sciences, Seoul, Republic of Korea
Department of Cell and Developmental Biology, Dental Research Institute, Seoul National University, Seoul, Republic of Korea
Department of Thoracic and Cardiovascular Surgery, University of Ulsan College of Medicine, Asan Medical Center, Seoul, Republic of Korea
Search for other papers by Eun-Ju Chang in
Google Scholar
PubMed
Asan Institute for Life Sciences, Seoul, Republic of Korea
Department of Cell and Developmental Biology, Dental Research Institute, Seoul National University, Seoul, Republic of Korea
Department of Thoracic and Cardiovascular Surgery, University of Ulsan College of Medicine, Asan Medical Center, Seoul, Republic of Korea
Search for other papers by Hyunsoo Kim in
Google Scholar
PubMed
Asan Institute for Life Sciences, Seoul, Republic of Korea
Department of Cell and Developmental Biology, Dental Research Institute, Seoul National University, Seoul, Republic of Korea
Department of Thoracic and Cardiovascular Surgery, University of Ulsan College of Medicine, Asan Medical Center, Seoul, Republic of Korea
Search for other papers by Yong Hee Kim in
Google Scholar
PubMed
Asan Institute for Life Sciences, Seoul, Republic of Korea
Department of Cell and Developmental Biology, Dental Research Institute, Seoul National University, Seoul, Republic of Korea
Department of Thoracic and Cardiovascular Surgery, University of Ulsan College of Medicine, Asan Medical Center, Seoul, Republic of Korea
Search for other papers by Hong-Hee Kim in
Google Scholar
PubMed
Asan Institute for Life Sciences, Seoul, Republic of Korea
Department of Cell and Developmental Biology, Dental Research Institute, Seoul National University, Seoul, Republic of Korea
Department of Thoracic and Cardiovascular Surgery, University of Ulsan College of Medicine, Asan Medical Center, Seoul, Republic of Korea
Search for other papers by Ghi Su Kim in
Google Scholar
PubMed
been addressed. We therefore tested the effects of α-LA on osteoblast-lineage cells and osteoclasts, and observed a dissociation of receptor activator of nuclear factor κB (NF-κB) ligand (RANKL) expression and osteoclastogenesis. That is, α-LA markedly
